Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/20/2021 73 14
Remdesivir Approved by FDA Experimental Antiviral Jan/19/2021 49 4
Anakinra  Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/05/2021 11 0
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/24/2020 4 2
Verteporfin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/09/2020 2 0
Azithromycin Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/04/2020 17 6
MVC-COV1901 Potential treatment - pre-clinical evidence Experimental Vaccine Nov/29/2020 2 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Nov/25/2020 19 5
C135-LS/C121-LS Potential treatment - pre-clinical evidence Experimental Antiviral Nov/19/2020 1 0
C135-LS/C144-LS Potential treatment - pre-clinical evidence Experimental Antiviral Nov/19/2020 1 0